June 25, 2014
In November of 2012, Johnson & Johnson, the parent company of DePuy, agreed to a $2.5 billion settlement for thousands of lawsuits over DePuy’s ASR hip implant devices.
In August of 2012, the company recalled over 93,000 of their metal-on-metal hip implant devices worldwide after it was discovered that the devices are prone to early failure and can cause serious medical problems including metallosis, or metal poisoning, which can lead to neurological problems and other side effects such as necrosis, swelling, and nerve, tissue, and muscle damage.
The November 2012 settlement compensated consumers for up to $250,000 for their injuries, however certain conditions applied. Qualified patients who have had revision surgery are entitled to up to $250,000 compensation if they underwent surgery before August 31, 2013, and those who agree to the settlement award waive their rights to future litigation against Johnson & Johnson concerning their ASR hip implant devices. In order for Johnson & Johnson to be bound by the settlement agreement, ninety-four percent of eligible patients must have enrolled in the settlement program by April 1, 2014.
While patients who have not undergone revision surgery and patients who have had revision surgery after August 31, 2013 are not eligible to participate in the settlement agreement, these individuals are not barred from seeking compensation for their injuries. An experienced attorney can help these individuals with their legal options.
The injuries associated with the DePuy ASR hip implant devices are very serious, and device failure could lead to lost wages, medical expenses, and pain and suffering. The attorneys at Khonsari Law Group are experienced in handling DePuy hip implant cases as well as products liability and medical malpractice cases. We understand the seriousness of what our clients are going through and are here to help. If you have any questions or concerns, please contact the Khonsari Law Group today.